U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
176641176641Study Evaluating rhMBP-2/CPM in Open Wedge OsteotomiesCompletedNo Results AvailableOsteoarthritisDrug: rhBMP-2/CPMhttps://ClinicalTrials.gov/show/NCT00243295
176642176642Randomized Controlled Trial of Mind-Body Breathing Therapy (in Chronic Obstructive Pulmonary Disease) To Improve Palliation of Dyspnea and Health-Related Quality of LifeCompletedNo Results AvailablePulmonary Disease, Chronic ObstructiveBehavioral: Relaxation Response (instruction, pocket practice card prov)|Behavioral: Mindfulness training using model developed from UMasshttps://ClinicalTrials.gov/show/NCT00243282
176643176643Acupressure and Relaxation for Nausea ControlCompletedHas ResultsNauseaBehavioral: Acupressure expectancy enhancementhttps://ClinicalTrials.gov/show/NCT00243269
176644176644Treatment of Obesity With Vitamin D (40.000 IE Per Week for 1 Year)CompletedNo Results AvailableObesityDrug: Cholecalciferolhttps://ClinicalTrials.gov/show/NCT00243256
176645176645Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major BurnCompletedHas ResultsBurnsDrug: Recombinant Factor VIIahttps://ClinicalTrials.gov/show/NCT00243243
176646176646Vicriviroc (SCH 417690) in Combination Treatment With Optimized ART Regimen in Experienced Subjects (VICTOR-E1) (Study P03672AM6)CompletedNo Results AvailableHIV InfectionsDrug: Vicriviroc maleate 20 mg|Drug: Vicriviroc maleate 30 mg|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00243230
176647176647Rotigotine Restless Legs Syndrome Dose Finding TrialCompletedNo Results AvailableIdiopathic Restless Leg SyndromeDrug: SPM 936https://ClinicalTrials.gov/show/NCT00243217
176648176648Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based ChemotherapyTerminatedNo Results AvailableCarcinoma, Non-Small Cell LungDrug: talabostat mesylate|Drug: docetaxelhttps://ClinicalTrials.gov/show/NCT00243204
176649176649Neoadjuvant Imatinib in Dermatofibrosarcoma ProtuberansCompletedHas ResultsDermatofibrosarcoma ProtuberansDrug: imatinib mesylatehttps://ClinicalTrials.gov/show/NCT00243191
176650176650Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE W)TerminatedNo Results AvailableAtrial Fibrillation|Vascular RiskDrug: clopidogrel (SR25990C)https://ClinicalTrials.gov/show/NCT00243178
176651176651Lifemel Honey to Reduce Leucopenia During ChemotherapyNot yet recruitingNo Results AvailableBreast CancerBehavioral: Lifemel honey intake every dayhttps://ClinicalTrials.gov/show/NCT00243165
176652176652Evaluation of Lamotrigine on Neuropathic Facial Pain Using fMRICompletedNo Results AvailableFacial NeuropathyDrug: Lamotriginehttps://ClinicalTrials.gov/show/NCT00243152
176653176653Mandibular Advancement Device for Obstructive Sleep ApneaCompletedNo Results AvailableSleep Apnea Syndromes|Sleep Apnea|Obstructive Sleep ApneaDevice: Mandibular advancement device (activator)https://ClinicalTrials.gov/show/NCT00243139
176654176654Family-based HIV Prevention for Adolescent GirlsCompletedNo Results AvailableHIV InfectionsBehavioral: Family-Based Risk Reduction Interventionhttps://ClinicalTrials.gov/show/NCT00243126
176655176655Docetaxel and Radiation Therapy in Treating Patients With Stage II or Stage III Cancer of the Larynx or HypopharynxCompletedNo Results AvailableHead and Neck CancerDrug: docetaxel|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00243113
176656176656Vorinostat and Gemcitabine in Treating Patients With Metastatic or Unresectable Solid TumorsCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificDrug: vorinostat|Drug: gemcitabine hydrochloridehttps://ClinicalTrials.gov/show/NCT00243100
176657176657Investigation of Safety, Tolerability and Maximum Tolerated Dose (MTD) of BI 2536 in Patients With Recurrent Advanced Aggressive Non-Hodgkin's Lymphoma (NHL)CompletedNo Results AvailableLymphomaDrug: BI 2536https://ClinicalTrials.gov/show/NCT00243087
176658176658S0509: AZD2171 in Treating Patients With Malignant Pleural Mesothelioma That Cannot Be Removed By SurgeryCompletedNo Results AvailableMalignant MesotheliomaDrug: cediranib maleatehttps://ClinicalTrials.gov/show/NCT00243074
176659176659AZD2171 in Treating Patients With Recurrent or Stage IV MelanomaCompletedHas ResultsAcral Lentiginous Malignant Melanoma|Ciliary Body and Choroid Melanoma, Medium/Large Size|Ciliary Body and Choroid Melanoma, Small Size|Extraocular Extension Melanoma|Intraocular Melanoma|Iris Melanoma|Lentigo Maligna Malignant Melanoma|Recurrent MelanomaDrug: cediranib maleatehttps://ClinicalTrials.gov/show/NCT00243061
176660176660Isoflavones and Radiation Therapy in Treating Patients With Localized Prostate CancerCompletedNo Results AvailableProstate CancerDietary Supplement: soy protein isolate|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00243048
176661176661Tipifarnib and Bortezomib in Treating Patients With Relapsed Multiple MyelomaTerminatedNo Results AvailableRefractory Multiple Myeloma|Stage II Multiple Myeloma|Stage III Multiple MyelomaDrug: bortezomib|Drug: tipifarnib|Other: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00243035
176662176662Dietary, Herbal and Alternative Medicine in Glioblastoma MultiformeTerminatedHas ResultsBrain and Central Nervous System Tumors|Cerebral EdemaDrug: Boswellia serrata extract|Dietary Supplement: cyanocobalaminhttps://ClinicalTrials.gov/show/NCT00243022
176663176663Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By SurgeryTerminatedNo Results AvailableKidney CancerDrug: cyclosporine|Drug: fludarabine phosphate|Drug: mycophenolate mofetil|Procedure: allogeneic bone marrow transplantation|Procedure: peripheral blood stem cell transplantation|Radiation: radiation therapyhttps://ClinicalTrials.gov/show/NCT00243009
176664176664Rituximab, Cyclophosphamide, and G-CSF Followed By Combination Chemotherapy in Treating Patients Who Are Undergoing Autologous Stem Cell Transplant Followed By Rituximab and GM-CSF for Refractory Diffuse Large B-Cell LymphomaActive, not recruitingNo Results AvailableLymphomaBiological: filgrastim|Biological: rituximab|Biological: sargramostim|Drug: carmustine|Drug: cyclophosphamide|Drug: etoposide|Procedure: adjuvant therapy|Procedure: bone marrow ablation with stem cell support|Procedure: peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00242996
176665176665Quality of Life in Patients Who Are Receiving Either Vinorelbine, Gemcitabine, and Docetaxel or Paclitaxel and Carboplatin for Advanced Non-Small Cell Lung CancerActive, not recruitingNo Results AvailableLung CancerProcedure: quality-of-life assessmenthttps://ClinicalTrials.gov/show/NCT00242983
176666176666Hypertrophic Scarring After Facial BurnCompletedNo Results AvailableBurnDevice: 3-Dimensional Color Scanninghttps://ClinicalTrials.gov/show/NCT00242970
176667176667The Intervention With Microfinance for AIDS and Gender Equity (IMAGE) StudyCompletedNo Results AvailableHIV Infections|Gender Based ViolenceBehavioral: Intervention with Microfinance for AIDS and Gender Equityhttps://ClinicalTrials.gov/show/NCT00242957
176668176668Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-ACS)CompletedNo Results AvailableCoronary Disease|HypercholesterolemiaDrug: Pitavastatin|Drug: Atorvastatinhttps://ClinicalTrials.gov/show/NCT00242944
176669176669Flu/TBI in Treating Patients Not Responding to Previous Hormone TherapyWithdrawnNo Results AvailableProstate CancerOther: Nonmyeloablative stem cell conditioning regimenhttps://ClinicalTrials.gov/show/NCT00242931
176670176670Safety and Effectiveness Study of Docetaxel and ZD1839 Followed by Removal of the Prostate to Treat Prostate CancerCompletedNo Results AvailableProstate CancerDrug: docetaxel|Drug: ZD1839https://ClinicalTrials.gov/show/NCT00242918

* Görseller ve İçerik tekif hakkına sahip olabilir